HCA Healthcare, Inc. $HCA is Epoch Investment Partners Inc.’s 10th Largest Position

Epoch Investment Partners Inc. cut its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 6.5% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 472,739 shares of the company’s stock after selling 32,805 shares during the quarter. HCA Healthcare accounts for about 1.2% of Epoch Investment Partners Inc.’s portfolio, making the stock its 10th largest holding. Epoch Investment Partners Inc. owned about 0.21% of HCA Healthcare worth $220,703,000 at the end of the most recent quarter.

Other institutional investors also recently bought and sold shares of the company. Palisade Asset Management LLC purchased a new position in HCA Healthcare during the 3rd quarter worth approximately $26,000. Holos Integrated Wealth LLC purchased a new position in HCA Healthcare during the 4th quarter worth approximately $29,000. Ares Financial Consulting LLC purchased a new position in HCA Healthcare during the 4th quarter worth approximately $31,000. JPL Wealth Management LLC purchased a new position in shares of HCA Healthcare during the 3rd quarter valued at approximately $33,000. Finally, Aventura Private Wealth LLC purchased a new position in shares of HCA Healthcare during the 4th quarter valued at approximately $34,000. 62.73% of the stock is owned by hedge funds and other institutional investors.

HCA Healthcare Stock Up 2.3%

HCA opened at $387.25 on Friday. HCA Healthcare, Inc. has a twelve month low of $330.00 and a twelve month high of $556.52. The company has a 50-day moving average price of $429.60 and a 200 day moving average price of $473.48. The company has a market cap of $85.91 billion, a PE ratio of 13.32, a price-to-earnings-growth ratio of 1.23 and a beta of 1.12.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings results on Friday, April 24th. The company reported $7.15 earnings per share for the quarter, missing the consensus estimate of $7.19 by ($0.04). HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.The company had revenue of $19.11 billion for the quarter, compared to analyst estimates of $19.09 billion. During the same quarter last year, the company earned $6.45 EPS. The firm’s revenue for the quarter was up 4.3% on a year-over-year basis. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, sell-side analysts expect that HCA Healthcare, Inc. will post 30.07 earnings per share for the current year.

HCA Healthcare Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 30th. Shareholders of record on Tuesday, June 16th will be paid a dividend of $0.78 per share. This represents a $3.12 annualized dividend and a yield of 0.8%. The ex-dividend date of this dividend is Tuesday, June 16th. HCA Healthcare’s payout ratio is 10.73%.

Analyst Ratings Changes

HCA has been the subject of several recent research reports. JPMorgan Chase & Co. cut their target price on shares of HCA Healthcare from $535.00 to $490.00 and set a “neutral” rating for the company in a report on Tuesday, May 19th. Sanford C. Bernstein cut their target price on shares of HCA Healthcare from $503.00 to $413.00 and set a “market perform” rating for the company in a report on Thursday, June 4th. UBS Group lifted their target price on shares of HCA Healthcare from $598.00 to $635.00 and gave the company a “buy” rating in a report on Monday, February 23rd. TD Cowen cut their target price on shares of HCA Healthcare from $561.00 to $500.00 and set a “buy” rating for the company in a report on Monday, April 27th. Finally, Oppenheimer cut their price target on shares of HCA Healthcare from $540.00 to $520.00 and set an “outperform” rating for the company in a report on Monday, April 27th. Fifteen analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $506.14.

HCA Healthcare Company Profile

HCA Healthcare is a for?profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.